Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena M Conti

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Health Affairs (Project Hope)|October 8, 2014
National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011Rena M Conti, Adam J Fein, Sumita S Bhatta
The Journal of Urology|December 29, 2015
National Economic Conditions and Patient Insurance Status Predict Prostate Cancer Diagnosis Rates and Management DecisionsAdam B Weiner, Rena M Conti, Scott E Eggener
Health Services Research|March 19, 2020
Relationship between initiation of 340B participation and hospital safety-net engagementSayeh S Nikpay, Melinda B Buntin, Rena M Conti
JAMA Health Forum|October 11, 2022
How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation?Rena M Conti, Richard G Frank, Len M Nichols
Health Affairs (Project Hope)|December 3, 2024
US Trends In Anticancer Medicine Pricing And The Impact Of Competition, 2014-20Rena M Conti, Claire Mcglave, Meredith B Rosenthal, et al.
Pediatrics|March 5, 2020
Pediatric Orphan Drug Indications: 2010-2018Lauren Kimmel, Rena M Conti, Anna Volerman, et al.
Journal of Law and the Biosciences|May 14, 2021
The geography of prescription pharmaceuticals supplied to the USA: levels, trends, and implicationsYashna Shivdasani, Neriman Beste Kaygisiz, Ernst R Berndt, et al.
Journal of Managed Care & Specialty Pharmacy|August 2, 2021
The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemiaRena M Conti, William V Padula, Russell V Becker, et al.
The Milbank Quarterly|January 29, 2024
Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed LiteratureTimothy W Levengood, Rena M Conti, Sean Cahill, et al.
JAMA Pediatrics|December 17, 2019
Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young AdultsKao-Ping Chua, Chad M Brummett, Rena M Conti, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Health Affairs (Project Hope)|October 8, 2014
National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011Rena M Conti, Adam J Fein, Sumita S Bhatta
The Journal of Urology|December 29, 2015
National Economic Conditions and Patient Insurance Status Predict Prostate Cancer Diagnosis Rates and Management DecisionsAdam B Weiner, Rena M Conti, Scott E Eggener
Health Services Research|March 19, 2020
Relationship between initiation of 340B participation and hospital safety-net engagementSayeh S Nikpay, Melinda B Buntin, Rena M Conti
JAMA Health Forum|October 11, 2022
How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation?Rena M Conti, Richard G Frank, Len M Nichols
Health Affairs (Project Hope)|December 3, 2024
US Trends In Anticancer Medicine Pricing And The Impact Of Competition, 2014-20Rena M Conti, Claire Mcglave, Meredith B Rosenthal, et al.
Pediatrics|March 5, 2020
Pediatric Orphan Drug Indications: 2010-2018Lauren Kimmel, Rena M Conti, Anna Volerman, et al.
Journal of Law and the Biosciences|May 14, 2021
The geography of prescription pharmaceuticals supplied to the USA: levels, trends, and implicationsYashna Shivdasani, Neriman Beste Kaygisiz, Ernst R Berndt, et al.
Journal of Managed Care & Specialty Pharmacy|August 2, 2021
The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemiaRena M Conti, William V Padula, Russell V Becker, et al.
The Milbank Quarterly|January 29, 2024
Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed LiteratureTimothy W Levengood, Rena M Conti, Sean Cahill, et al.
JAMA Pediatrics|December 17, 2019
Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young AdultsKao-Ping Chua, Chad M Brummett, Rena M Conti, et al.
Pageof 14